6926-58-5Relevant articles and documents
Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin
Wang, Jun,Gou, Yi,Zhang, Zhenlei,Yu, Ping,Qi, Jinxu,Qin, Qipin,Sun, Hongbin,Wu, Xiaoyang,Liang, Hong,Yang, Feng
, p. 2180 - 2193 (2018/05/15)
Designing a multitarget anticancer drug with improved delivery and therapeutic efficiency in vivo presents a great challenge. Thus, we proposed to design an anticancer multitarget metal pro-drug derived from thiosemicarbazone based on the His146 residue i
FULLY-MODIFIED PHENYL PYRROLE AMINOGUANIDINES
-
Page/Page column 74, (2009/07/17)
The invention relates to phenyl pyrrole aminoguanidines modified at the guanidine group of the general formula (I), including tautomeric and isomeric forms thereof, wherein, X is (II) and i is 0,1or 2, Y is (III) and j is 0 or 1; wherein Q is nitrogen (N)
Thiocarbamoylation of amine-containing compounds 6. Reactions of tetramethylthiuram disulfide with hydrazones of aromatic aldehydes
Boi, Luu Van,Floria, V.
, p. 344 - 347 (2007/10/03)
Thiocarbamoylation of hydrazones of aromatic aldehydes with tetramethylthiuram disulfide (TMTD) afforded diarylaldazines, 4,4-dimethylthiosemicarbazide, and 5-dimethylamino-l,3,4-thiadiazole-2-thiol. In addition, the reaction of TMTD with salicylaldehyde